Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-063300

SVP & Chief Financial Officer acquired 28,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2018-12-14 Grant or award +28,750 135,294 D
Derivatives
Labrucherie Gil M SVP & Chief Financial Officer 2018-12-14 Grant or award · Stock Option +58,100 58,100 D
Loading xslF345X03/doc4.xml…